Tous les communiqués | WebDisclosure

COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 10:05, il y a 2 mois 18 jours

'CART BP' Demonstrates Successful Blood Pressure Monitoring in Microgravity
'CART BP' successfully measures blood pressure in microgravity environment during the IIAS-02 mission. Collaboration between University of Cambridge and IIAS highlights potential for continuous monitoring. Sky Labs' ring-shaped device shows promise for space health initiatives

Blood Pressure Monitoring Microgravity Sky Labs CART BP Space Health
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:45, il y a 2 mois 18 jours

Biggest Office Party Night of The Year Set for Unprecedented Surge in 0.0 Drinking
Global study by Heineken® 0.0 reveals changing attitudes towards alcohol, with 72% confident to skip alcohol at festive events without judgment. People embrace saying 'no' to alcohol in 2025, leading to a surge in confidence and social acceptance

Global Study Festive Season Social Acceptance Heineken 0.0 Alcohol Attitudes
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:30, il y a 2 mois 18 jours

tick Trading Software AG: TBMX WebTrader securities trading platform wins Red Dot Award
tick Trading Software AG's TBMX WebTrader securities trading platform wins Red Dot Award for Interface & User Experience Design, showcasing commitment to advanced technology and user-centric design

Tick Trading Software AG Red Dot Award TBMX WebTrader Securities Trading Platform User Experience Design
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:05, il y a 2 mois 18 jours

mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
mAbxience and HP collaborate on AI solution to optimize biomanufacturing and biosimilar development, enhancing predictability and efficiency. Project aims to improve patient access to biologic therapies

AI Solution Biosimilar Development Biomanufacturing MAbxience HP
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:05, il y a 2 mois 18 jours

Alessandro Capone Appointed CEO of TIC Holding Schweiz AG
Alessandro Capone appointed CEO of TIC Holding Schweiz AG. Swiss national with 20 years of experience in building testing laboratories. TIC Holding aims to become a leading corporate group in accredited testing, inspection, and certification services

Switzerland CEO TIC Holding Schweiz AG Accredited Testing Alessandro Capone
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:05, il y a 2 mois 18 jours

Sunshare Debuts "Glory" at Solar Solutions Düsseldorf: Redefining Balcony Solar Safety with EV-Grade Semi-Solid Tech
Sunshare introduces 'Glory' balcony solar storage system at Solar Solutions Düsseldorf, featuring EV-Grade Semi-Solid Tech for enhanced safety and longevity

Safety Sunshare Glory Balcony Solar EV-Grade Semi-Solid Tech
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:05, il y a 2 mois 18 jours

S.Pellegrino Announces Long-term Partnership with Ferrari to Inspire Consumers to Bring Their Best
S.Pellegrino announces a long-term partnership with Ferrari to inspire consumers to bring their best, aiming to elevate lifestyle positioning and engage younger audiences globally

Partnership Consumer Experiences S.Pellegrino Ferrari Italian Heritage
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:00, il y a 2 mois 18 jours

Official List Notice
Financial Conduct Authority admits new securities to the Official List due to latest notice. Various debt securities issued by different entities included

Securities Financial Conduct Authority Debt Official List Issuers
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:00, il y a 2 mois 18 jours

Premier Miton Global Renewables Trust PLC - Amendment Notice
Premier Miton Global Renewables Trust PLC's securities amended by Financial Conduct Authority. Ordinary Shares updated with new rights for trading

Ordinary Shares Financial Conduct Authority Investment Funds Securities Amendment Premier Miton Global Renewables Trust PLC
COMMUNIQUÉ DE PRESSE

publié le 04/12/2025 à 09:00, il y a 2 mois 18 jours

AUTO1 Group raises inventory financing capacity to EUR 1.6 billion to power continued growth
AUTO1 Group SE raises inventory financing capacity to EUR 1.6 billion, expanding bank group and improving financing terms to fuel growth across Europe

Growth AUTO1 Group Inventory Financing Bank Group EUR 1.6 Billion

Publié le 20/02/2026 à 19:29, il y a 1 jour 21 heures

SFPI GROUP: Liquidity agreement report S2 2025
Publié le 20/02/2026 à 19:29, il y a 1 jour 21 heures

SFPI GROUP: bilan du contrat de liquidité S2 S025
Publié le 20/02/2026 à 18:00, il y a 1 jour 22 heures

TERACT - Termination of liquidity agreement
Publié le 20/02/2026 à 18:00, il y a 1 jour 22 heures

TERACT - Résiliation du contrat de liquidité
Publié le 20/02/2026 à 17:35, il y a 1 jour 23 heures

CHIFFRE D'AFFAIRES 2025

Voir tout LES ECHOS COMFI WIRE

Publié le 21/02/2026 à 00:45, il y a 1 jour 16 heures

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Publié le 21/02/2026 à 00:30, il y a 1 jour 16 heures

Redwood AI Corp. Announces Engagement for IR Services
Publié le 20/02/2026 à 23:15, il y a 1 jour 17 heures

DigiPower X Announces Closing of Settlement
Publié le 20/02/2026 à 23:00, il y a 1 jour 17 heures

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Publié le 20/02/2026 à 22:17, il y a 1 jour 18 heures

Organto Foods Completes Warrant Exercise Incentive Program

Voir tout ACCESSWIRE

Publié le 22/02/2026 à 12:19, il y a 4 heures 33 minutes

Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Publié le 22/02/2026 à 10:09, il y a 6 heures 43 minutes

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Publié le 21/02/2026 à 12:00, il y a 1 jour 4 heures

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Publié le 21/02/2026 à 12:00, il y a 1 jour 4 heures

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Publié le 20/02/2026 à 18:36, il y a 1 jour 22 heures

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share

Voir tout EQS

News